Study of the Safety and Efficacy of Intravenous Alpha-1 Antitrypsin in Type 1 Diabetes Mellitus

NCT01304537 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 1 Diabetes Mellitus

Interventions

DRUG: Alpha-1 Antitrypsin 40mg (AAT, Glassia®)
DRUG: Alpha-1 Antitrypsin 60mg (AAT, Glassia®)
DRUG: Alpha-1 Antitrypsin 80mg (AAT, Glassia®)

Sponsor

Kamada, Ltd.